This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_CERVIX_UTERI_ENDOCERVIX_EXALLC for full statistics.
Carcinoma in situ of cervix uteri, endocervix
CD2_INSITU_CERVIX_UTERI_ENDOCERVIX
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
438 |
4. Check minimum number of eventsNone |
438 |
5. Include endpointsNone |
438 |
6. Filter based on genotype QC (FinnGen only) |
438 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D06
- Name in latin
- Carcinoma in situ endocervicis (uteri)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of cervix uteri, endocervix
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of cervix uteri, endocervix
- HSIL lesion of the cervix uteri
- HSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri
- All dysplastic lesions of the cervix uteri, vagina or vulva
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 438 | 438 | - |
| Unadjusted period prevalence (%) | 0.15 | 0.15 | - |
| Median age at first event (years) | 38.86 | 38.86 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 381
- Matched controls
- 3810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
+∞
323.0
381
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
63.7
225.5
273
145
ULA02
NOMESCO Finland
Kolposcopy
34.8
189.0
299
361
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
33.6
186.2
302
388
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
1915.2
140.9
128
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
16.9
129.9
269
474
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
19.2
124.1
215
240
LDA10
NOMESCO Finland
Curettage of cervix uteri
21.2
102.3
161
127
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
24.2
85.8
126
76
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
459.4
77.8
75
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
25.3
69.2
99
52
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
191.5
63.1
64
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
132.1
34.3
36
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
326.9
30.2
30
*
8140/2-C53.0
ICD-O-3
Adenocarcinoma in situ, NOS, of endocervix
+∞
27.4
26
*
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
26.4
25
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
7.5
25.5
63
98
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
255.3
23.9
24
*
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.5
23.6
53
71
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
7.5
22.5
55
84
LEB00
NOMESCO Finland
Biopsy of vagina
11.3
21.2
40
39
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
9.2
20.8
44
53
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.6
17.7
217
1287
ZXC00
NOMESCO Finland
Use of diathermy
22.2
17.5
25
12
LCD10
NOMESCO Finland
Vaginal hysterectomy
7.7
17.4
41
59
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
31.6
16.3
21
7
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
47.0
15.2
18
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
83.4
14.7
16
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
155.7
14.6
15
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.8
13.9
101
431
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
13.6
13
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.7
12.5
99
442
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.8
12.1
40
90
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
13.1
11.8
20
16
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
31.1
11.7
15
5
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
123.6
11.5
12
*
C539, 6666, 0
ICD-O-3
NA
9.3
11.4
23
26
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.4
11.2
41
102
N87.0
ICD-10 Finland
Mild cervical dysplasia
5.0
11.1
35
75
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
33.5
10.4
13
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.0
10.1
24
36
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.0
9.9
18
17
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
56.5
9.7
11
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
102.5
9.5
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
11.1
8.9
16
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.9
8.5
34
93
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
92.0
8.4
9
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
8.4
8
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
34.1
8.1
10
*
WX402
NOMESCO Finland
General anaesthesia
2.2
8.1
86
439
G01AA10
ATC
clindamycin; vaginal
2.1
7.9
107
605
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
81.6
7.4
8
*
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
105
622
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.7
6.6
21
47
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
6.5
32
105
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
8.4
6.4
13
16
B01AB10
ATC
tinzaparin; parenteral
3.1
6.3
32
108
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
108
268
5.02
41.98
2.7
1.5
—
—
—
0
0
237
1260
2.92
26.81
2.6
1.5
—
—
—
0
0
24
35
7.20
15.85
2.8
1.7
—
—
—
0
0
66
313
2.31
8.12
1.8
2.4
21.4
36.9
u/ml
1.07
61
303
232
1775
1.65
6.21
3.7
3.8
—
—
—
0
0
232
1828
1.57
5.13
4.3
4.2
0.0
0.0
estimate
0.50
63
365
52
272
2.03
4.99
2.1
2.7
—
—
—
0
0
233
1849
1.56
4.91
3.2
3.0
0.0
0.0
estimate
0.50
62
352
166
1249
1.53
4.30
3.5
4.2
36.8
36.9
g/l
0.11
153
1169
180
1430
1.44
3.37
3.2
3.0
—
—
—
0
0
390
3641
1.65
2.75
9.6
9.9
3.9
3.9
mmol/l
0.33
380
3534
216
1822
1.37
2.66
3.1
3.0
0.0
0.0
estimate
0.50
62
360
388
3632
1.60
2.53
9.6
9.8
139.6
139.6
mmol/l
0.04
379
3536
106
810
1.41
2.34
2.5
2.4
0.3
0.3
e6/l
0.26
82
586
371
3454
1.48
2.32
9.0
8.4
91.5
91.6
ml/min/173m2
0.05
314
2785
131
1057
1.34
2.05
2.7
2.7
—
—
—
0
0
105
820
1.37
2.03
1.8
1.8
—
—
—
0
0
35
219
1.65
1.98
3.1
3.2
1.2
1.2
mmol/l
0.48
28
190
118
947
1.34
1.90
3.3
3.3
0.0
0.0
estimate
0.80
63
362
63
458
1.44
1.84
2.2
2.2
1.4
1.1
e6/l
0.41
40
237
208
1818
1.27
1.75
3.4
4.0
6.4
6.3
mmol/l
0.27
199
1636
394
3771
1.45
1.53
9.9
10.1
21.6
18.0
mg/l
1.36
314
2860
409
3951
1.53
1.42
8.8
8.5
23.5
23.7
u/l
0.08
397
3856
6
23
2.63
1.37
1.0
1.1
1308.0
1661.9
miu/ml
—
6
23
9
43
2.12
1.31
1.8
1.3
—
—
—
0
0
19
296
0.63
1.19
1.2
1.6
203.4
319.0
mu/l
3.02
14
266
20
126
1.62
1.16
3.9
4.7
24.5
24.7
mmol/l
0.08
20
126
56
438
1.32
1.10
2.3
2.3
5.3
4.5
e6/l
0.15
33
216
7
32
2.21
1.08
1.0
1.3
—
—
—
0
0
8
147
0.54
1.05
1.9
1.6
—
—
—
0
0
10
53
1.91
1.02
1.0
1.3
—
—
—
0
0
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
123
1072
1.20
0.97
3.2
3.0
2.3
2.3
mmol/l
1.03
115
974
74
886
0.80
0.96
1.6
1.6
1.3
1.4
mmol/l
0.27
62
774
17
109
1.58
0.95
10.4
7.2
23.9
23.9
mmol/l
0.01
17
104
32
235
1.39
0.95
7.2
8.6
-0.0
1.0
mmol/l
0.70
25
178
59
478
1.27
0.91
1.3
1.3
31.8
26.3
iu/l
0.52
50
418
24
334
0.70
0.91
1.7
1.5
—
—
—
0
0
21
297
0.69
0.87
1.3
1.7
—
—
—
0
0
164
1481
1.17
0.85
5.4
5.6
1.2
1.2
mmol/l
0.21
128
1258
13
80
1.64
0.85
3.5
2.5
1.4
1.4
mg/l
0.08
13
72
55
446
1.27
0.85
1.5
1.6
—
—
—
0
0
10
166
0.59
0.85
1.7
1.8
—
—
—
0
0
6
32
1.89
0.82
2.2
1.3
—
—
—
0
0
8
47
1.71
0.81
2.4
2.1
—
—
—
0
0
23
315
0.72
0.81
1.6
1.4
—
—
—
0
0
23
314
0.72
0.79
1.6
1.4
—
—
—
0
0
309
3231
0.85
0.79
4.2
4.6
14.2
14.3
pmol/l
0.36
285
3053
60
497
1.24
0.78
2.3
2.3
2.4
2.4
mmol/l
0.12
53
439
23
313
0.72
0.78
1.6
1.4
—
—
—
0
0
23
313
0.72
0.78
1.6
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
94
1074
0.84
0.76
1.3
1.2
0.5
2.0
u/ml
1.96
33
305
378
3667
1.22
0.74
10.9
10.9
39.0
39.6
%
0.79
313
3062
12
76
1.60
0.72
2.5
3.5
3.3
4.3
e9/l
1.31
12
76
12
76
1.60
0.72
2.5
3.8
53.4
57.2
%
0.57
12
76
5
26
1.93
0.71
1.0
1.3
—
—
—
0
0
312
3248
0.86
0.69
3.7
3.9
—
—
—
0
0
143
1303
1.14
0.64
4.9
4.9
1.2
1.2
mmol/l
0.22
124
1196
69
594
1.19
0.64
1.7
1.7
—
—
—
0
0
15
104
1.46
0.63
3.9
2.6
7.7
9.6
mg/l
0.67
15
95
131
1189
1.15
0.62
1.6
1.8
94.2
99.4
pmol/l
0.49
68
659
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
12
80
1.51
0.60
1.1
1.2
—
—
—
0
0
172
1595
1.13
0.59
2.0
2.3
74.4
75.1
nmol/l
0.14
157
1492
10
149
0.66
0.57
1.3
1.3
—
—
—
0
0
41
339
1.23
0.57
4.4
4.2
—
—
—
0
0
24
185
1.31
0.57
2.0
2.9
1.6
2.0
mmol/l
0.25
17
145
5
86
0.58
0.56
1.8
2.0
12.5
13.3
%
—
5
86
94
840
1.15
0.56
1.9
1.9
—
—
—
0
0
24
187
1.30
0.54
2.0
2.9
5.8
5.8
kpa
0.10
24
182
341
3503
0.88
0.49
3.3
3.5
5.6
5.6
mmol/l
0.15
320
3298
103
935
1.13
0.49
2.0
2.0
—
—
—
0
0
22
277
0.78
0.48
1.0
1.1
—
—
—
0
0
117
1272
0.89
0.48
3.1
2.9
27.7
27.6
u/l
0.01
108
1223
24
191
1.27
0.47
1.5
1.7
—
—
—
0
0
12
85
1.42
0.47
1.0
1.6
—
—
—
0
0
17
221
0.76
0.47
1.5
1.3
206.1
231.6
miu/ml
—
9
111
7
50
1.41
0.45
1.6
1.0
—
—
—
0
0
22
273
0.80
0.44
1.2
1.5
—
—
—
0
0
357
3487
1.13
0.42
3.0
3.2
1.2
1.2
mmol/l
0.41
335
3305
343
3345
1.12
0.41
12.1
12.3
13.3
13.5
%
2.38
335
3292
221
2112
1.09
0.40
8.7
8.1
3.7
3.9
e9/l
0.83
205
1862
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
88
804
1.12
0.39
1.4
1.3
24.8
25.7
iu/ml
0.04
34
279
20
246
0.80
0.38
1.6
1.8
3.0
2.8
mg/l
0.06
14
162
15
116
1.30
0.37
12.9
8.0
94.1
94.7
%
0.21
15
116
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
12
90
1.34
0.36
1.0
1.3
—
1.6
—
0
7
5
79
0.63
0.36
1.4
2.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
33
382
0.85
0.35
2.3
1.8
30.0
29.3
s
0.39
33
376
281
2726
1.09
0.34
4.0
3.8
10.1
9.2
mm/h
0.46
264
2569
11
83
1.33
0.32
1.0
1.3
—
—
—
0
0
12
92
1.31
0.32
1.9
2.2
1.5
1.2
%
0.28
12
92
41
362
1.15
0.31
2.6
3.3
29.5
32.5
%
1.07
29
265
11
142
0.77
0.31
1.4
2.3
—
—
—
0
0
33
287
1.16
0.31
1.8
1.5
—
—
—
0
0
36
409
0.87
0.31
1.4
1.6
—
—
—
0
0
205
2128
0.93
0.29
2.9
2.9
73.8
62.9
ug/l
0.85
194
2030
49
542
0.89
0.29
1.5
1.5
—
—
—
0
0
50
454
1.11
0.26
1.7
1.6
1217.0
1141.2
nmol/l
0.20
35
358
20
169
1.19
0.26
3.6
2.2
41.4
38.4
u/l
0.32
20
154
5
72
0.69
0.26
1.6
1.4
—
—
—
0
0
108
1143
0.93
0.26
1.5
1.6
—
—
—
0
0
9
72
1.26
0.26
1.1
1.6
—
—
—
0
0
72
774
0.92
0.25
2.0
2.1
292.6
4494.5
umol/l
2.78
62
698
29
255
1.15
0.25
8.1
5.4
103.7
104.7
mmol/l
0.46
29
249
32
359
0.88
0.24
1.4
1.5
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
59
636
0.92
0.22
1.6
1.6
440.1
36204301.2
pmol/l
1.05
47
569
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
1.2
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
60.5
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
83
879
0.93
0.21
1.7
1.7
0.7
0.7
mg/l
0.01
62
658
11
134
0.82
0.21
1.6
3.1
1.7
1.3
mmol/l
0.15
11
95
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
19
218
0.87
0.20
1.4
1.7
—
—
—
0
0
6
50
1.20
0.20
1.0
1.3
—
—
—
0
0
45
487
0.92
0.19
1.9
3.0
34.4
374.8
ng/l
1.22
19
264
49
528
0.92
0.19
1.4
1.5
—
—
—
0
0
82
865
0.94
0.19
1.9
2.0
2.5
2.7
mg/l
0.57
64
754
361
3652
0.93
0.18
4.8
5.2
1.7
2.0
mu/l
0.52
332
3484
11
132
0.83
0.18
1.0
1.1
—
—
—
0
0
21
185
1.14
0.18
1.2
1.5
—
—
—
0
0
40
434
0.91
0.18
1.3
1.2
167.2
172.9
iu/ml
—
8
187
11
92
1.20
0.16
1.1
1.3
—
—
—
0
0
268
2633
1.05
0.16
7.1
6.3
69.5
72.9
u/l
1.01
255
2480
6
76
0.79
0.15
1.3
1.1
—
—
—
0
0
10
119
0.84
0.15
1.6
1.8
—
—
—
0
0
84
803
1.06
0.15
1.2
1.3
9.1
13.7
u/ml
0.25
36
341
91
874
1.05
0.14
1.7
2.0
106.1
121.1
u/l
0.53
84
834
23
251
0.91
0.12
2.1
2.2
80.0
78.6
ml/min/173m2
—
8
96
316
3190
0.97
0.10
4.1
4.3
37.5
37.7
mmol/mol
0.24
299
3024
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
5
46
1.09
0.09
1.2
1.2
—
—
nmol/l
—
0
0
13
145
0.89
0.09
1.2
1.1
—
4.3
—
0
27
11
124
0.88
0.09
1.0
1.2
—
—
—
0
0
6
54
1.11
0.09
1.2
1.4
25.9
30.1
nmol/l
—
6
45
24
257
0.93
0.08
1.3
1.6
—
—
—
0
0
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
7
66
1.06
0.08
9.4
6.6
323.9
375.1
umol/l
—
7
57
14
128
1.10
0.06
1.1
1.3
—
—
—
0
0
8
95
0.84
0.06
2.5
2.2
3.8
3.7
g/l
—
8
90
69
671
1.03
0.06
1.4
1.4
18.6
21.7
nmol/l
1.20
59
591
41
394
1.04
0.06
2.8
2.2
27.4
23.7
%
0.85
36
336
171
1687
1.02
0.06
5.6
5.0
8.7
9.5
umol/l
0.89
166
1592
54
523
1.04
0.06
1.8
1.6
1.4
1.3
%
0.32
46
478
10
111
0.90
0.06
1.4
1.7
—
—
—
0
0
272
2698
1.02
0.06
2.8
2.8
33.3
34.2
u/l
0.10
264
2583
54
527
1.03
0.04
2.2
2.7
639.0
783.8
ng/l
0.15
43
432
10
109
0.92
0.04
1.1
1.2
—
35.8
—
0
8
18
190
0.95
0.04
1.6
1.9
—
—
—
0
0
103
1017
1.02
0.03
2.4
2.6
22.0
18.5
ng/l
0.19
37
456
362
3632
0.98
0.03
3.2
3.5
1.6
1.6
mmol/l
0.12
340
3454
19
199
0.95
0.03
10.3
5.2
1.2
1.2
mmol/l
0.00
19
191
13
123
1.06
0.01
1.0
1.2
—
2.9
—
0
16
31
317
0.98
0.01
4.2
4.9
1.0
1.0
mmol/l
0.92
31
295
102
1013
1.01
0.01
2.3
2.2
48.8
55.5
u/l
2.16
96
939
11
116
0.95
0.00
1.1
1.1
0.3
1.4
u/ml
—
5
46
38
386
0.98
0.00
1.6
2.2
3.7
5.1
umol/l
2.11
26
334
12
124
0.97
0.00
1.1
1.1
—
—
—
0
0
12
123
0.97
0.00
1.0
1.2
—
—
—
0
0
16
163
0.98
0.00
1.7
1.5
—
—
—
0
0
26
257
1.01
0.00
1.3
1.5
—
—
—
0
0
26
263
0.99
0.00
1.3
1.6
—
—
—
0
0
13
132
0.98
0.00
1.1
1.3
2.2
2.5
ug/l
0.26
13
118
12
119
1.01
0.00
1.3
1.5
—
—
—
0
0
38
381
1.00
0.00
2.0
2.0
1432.3
5239.8
u/l
1.26
15
156
365
3646
1.01
0.00
3.3
3.6
4.9
4.9
mmol/l
0.76
346
3480
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
6.7
12.0
1.5
1.2
inr
—
7
36
25
250
1.00
0.00
4.9
3.4
207.5
233.1
u/l
0.89
25
242
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
368
3680
1.00
0.00
3.4
3.8
3.0
2.9
mmol/l
0.83
345
3494
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_ENDOCERVIX – Carcinoma in situ of cervix uteri, endocervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).